Clinical Evaluation of the Photoallergy Potential of Xenaderm Ointment
NCT ID: NCT00645164
Last Updated: 2010-06-08
Study Results
Outcome measurements, participant flow, baseline characteristics, and adverse events have been published for this study.
View full resultsBasic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
PHASE1
59 participants
INTERVENTIONAL
2008-03-31
2008-06-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Clinical Evaluation of the Phototoxic Potential of Xenaderm Ointment
NCT00644917
Phototoxicity Test of Dapsone Gel in Healthy Volunteers
NCT02108483
Penicillin Skin Testing in Patients With History of Allergic Reactions to Betalactams
NCT00789217
Evaluation of the Allergenicity of AMPHADASE INJECTION (Hyaluronidase Injection USP)
NCT01689363
Photoallergy Potential of Dapsone Gel in Healthy Volunteers
NCT02117739
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
NA
SINGLE_GROUP
QUADRUPLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Xenaderm
Subject serves as own control
Ointment Vehicle
Subject acts as own control. 20 mg under Finn chambers
Xenaderm
20 mg under Finn chambers
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Ointment Vehicle
Subject acts as own control. 20 mg under Finn chambers
Xenaderm
20 mg under Finn chambers
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
Exclusion Criteria
18 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Healthpoint
INDUSTRY
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Healthpoint
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Joe Stanfield, PhD
Role: PRINCIPAL_INVESTIGATOR
Suncare Research Laboratories
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Suncare Research Laboratories
Winston-Salem, North Carolina, United States
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
011 101 09 002
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.